Skip to main content
Fig. 2 | Cancer Imaging

Fig. 2

From: FDG-PET/CT imaging for evaluating durable responses to immune check point inhibitors in patients with advanced cutaneous squamous cell carcinoma

Fig. 2

68 year old man with imaging for advanced cutaneous squamous cell carcinoma involving the right skull base, right infratemporal fossa and right trigeminal nerve managed with cemiplimab 350 mg/3-weekly. a demonstrating avid disease at baseline and (b) a CMR post 24 cycles. c demonstrating 41 × 23 mm enhancing mass on baseline MRI and (d) an ongoing RECIST1.1 PR post 24 cycles

Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us